Oncology & Cancer
Confining cell-killing treatments to tumors
Cytokines, small proteins released by immune cells to communicate with each other, have for some time been investigated as a potential cancer treatment.
Jun 26, 2019
0
0
Page 9 - News tagged with chimeric antigen receptor
Oncology & Cancer
Researchers characterize mechanism of action of CAR T cells
The scientific community has made great strides over the past decade in the development of a new class of cancer therapy called immunotherapy, a treatment that activates a patient's own immune system to target cancer cells. ...
Feb 14, 2019
0
38
Oncology & Cancer
Study highlights the importance of infection prevention after CAR T-cell therapy
Researchers at Dana-Farber Cancer Institute, in collaboration with colleagues from Memorial Sloan Kettering Cancer Center in New York (Dr. Kai Rejeski) and the LMU Hospital in Munich, Germany (Dr. Tobias Tix), have found ...
Jul 8, 2024
0
6
Oncology & Cancer
Study shows CAR NK cells with CD28 costimulation improve cell persistence and antitumor activity
Adding CD28 costimulation to cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cells targeting CD70+ cancers significantly enhanced antitumor efficacy and long-term cytotoxicity of the CAR NK cells, according ...
Jun 20, 2024
0
1
Oncology & Cancer
Researchers explore present and future treatment options for hepatocellular carcinoma using immunotherapy
Hepatocellular carcinoma (HCC), a prevalent form of cancer, profoundly influences the progression and prognosis of the disease through immune response mechanisms. The tumor microenvironment plays a pivotal role in fostering ...
May 22, 2024
0
0
Immunology
Breakthrough therapies are saving lives, but can we afford them?
Harnessing the body's own cells to fight disease, long a medical dream, is finally a reality.
May 13, 2024
0
0
Oncology & Cancer
CD7 CAR T-cell therapy, stem-cell transplant beneficial for CD7-positive tumors
For patients with relapsed or refractory CD7-positive leukemia or lymphoma, sequential CD7 chimeric antigen receptor (CAR) T-cell therapy followed by haploidentical hematopoietic stem-cell transplantation (HSCT) is safe and ...
Apr 25, 2024
0
1
Neuroscience
EEG most beneficial tool for managing CAR T-cell-related neurotoxicity
For patients with immune effector cell-associated neurotoxicity syndrome (ICANS) due to chimeric antigen receptor (CAR) T-cell therapy, electroencephalogram (EEG) has the greatest therapeutic impact, according to a study ...
Apr 8, 2024
0
1
Immunology
CARv3-TEAM-E T-cell treatment beneficial for recurrent glioblastoma
For patients with recurrent glioblastoma, treatment with chimeric antigen receptor (CAR) T-cells engineered to target the epidermal growth factor receptor (EGFR) variant III tumor-specific antigen, in addition to the wild-type ...
Mar 23, 2024
0
2
Oncology & Cancer
New research results explore the safety of short-term cultivated CAR T cells in cancer immunotherapy
Chimeric antigen receptor T cells—CAR T cells for short—are immune cells (T cells) that are taken from the body and genetically modified outside the body in the laboratory using transport vehicles for the genes to be ...
Mar 22, 2024
0
0
